Status:
NOT_YET_RECRUITING
Telerehabilitation Versus Supervised Pelvic Floor Muscle Training in Urinary Incontinence
Lead Sponsor:
Riphah International University
Conditions:
Urinary Incontinence
Urinary Incontinence,Stress
Eligibility:
FEMALE
45-65 years
Phase:
NA
Brief Summary
Urinary Incontinence (UI) is a prevalent condition impacting women across all age groups, varing in both severity and type. Urinary Incontinence affects 25%-45% of women worldwide. A systematic review...
Detailed Description
Urinary incontinence (UI) is common among postmenopausal women and is characterized by involuntary urine leakage, leading to physical, psychological, and social challenges. Its prevalence increases af...
Eligibility Criteria
Inclusion
- Postmenopausal women between the ages of 45-65.
- Postmenopausal status, defined as absence of menstruation for more than 12 months.
- Experiencing symptomatic urinary incontinence, indicated by a Questionnaire for Urinary Incontinence Diagnosis (QUID) score greater than "0".
- Able to comprehend and accurately respond to the questionnaire (i.e., no language barriers) and reading and writing Urdu language.
- Free from any physical or psychological conditions that could hinder participation in the study.
- Participants must have access to both the internet and a mobile phone/laptop
- Signing the informed consent form.
Exclusion
- Women with cognitive impairments, neurological disorders, pelvic malignancies.
- Individuals with a history of intra-abdominal and pelvic surgery or radiation therapy.
- Presence of active urinary tract/vaginal infection
- Presence of incontinence except stress and urge urinary incontinence (e.g. overflow incontinence or dribbling urine after urination)
- Presence of voiding dysfunction (e.g. incomplete voiding, intermittent urination or delay in starting to urinate)
- Women with contraindications to pelvic floor muscle training (e.g., pelvic pain resulting from endometriosis, coccydynia or anismus, unexplained vaginal bleeding and anal fissure).
- Women aged over 65 years
- Body mass index ≥ 27.4 kg/m²
- Currently undergoing hormone therapy
- Lack of pelvic floor muscle contraction ability (pelvic floor muscle strength \<2 according to the Modified Oxford Scale)
Key Trial Info
Start Date :
January 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT07151170
Start Date
January 1 2026
End Date
July 1 2026
Last Update
December 1 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Riphah International Hospital
Islamabad, Islamabad, Pakistan, 44000
2
Pakistan Railway Hospital
Rawalpindi, Punjab Province, Pakistan, 40100